GATA3 and bladder transitional cell carcinoma: Next, patients were categorized into high (n = 45) and low (n = 45) GATA3-AS1 expression groups, based on median values from RT-qPCR data, and associations between GATA3-AS1 levels and BLCA clinical features analyzed.